Betaserc 8 mg 100 tablets
Composition:
Each tablet contains betahistine dihydrochloride 8 mg.
Excipients:
microcrystalline cellulose, mannitol, citric acid monohydrate, colloidal silicon dioxide, talc.
Product Description:
- Betaserc is a synthetic analogue of histamine.
- It acts mainly on histamine H1‑receptors, causes precapillary dilation, and improves microcirculation in the labyrinth.
- It regulates endolymphatic pressure in the labyrinth and cochlea, leading to clinical improvement in vertigo of various origins.
- It reduces the frequency and intensity of dizziness, decreases tinnitus, and helps improve hearing.
- It may increase the tone of smooth muscles in the bronchi and gastrointestinal tract, and can enhance gastric juice secretion.
Indications for Use:
Ménière’s syndrome,
manifested by dizziness (with nausea and vomiting),
hearing loss (hypoacusis), and tinnitus.
Symptomatic treatment of vestibular vertigo.
Method of Administration and Dosage:
The optimal dosing regimen is determined by the physician.
Single dose: 8–16 mg, taken three times daily.
Treatment is long‑term.
To reduce dyspeptic symptoms, it is recommended to take during or after meals.
Contraindications:
- Hypersensitivity to betahistine.
- Pheochromocytoma.
- Peptic ulcer of the stomach or duodenum in the acute phase.
- Bronchial asthma.
- First trimester of pregnancy.
- Use with caution in the second and third trimesters, during breastfeeding, and in children.
Precautions:
Use cautiously in patients with a history of gastric or duodenal ulcer.
Clinical effect is achieved after several months of treatment.
Adverse Reactions / Side Effects:
Gastrointestinal: mild nausea, feeling of heaviness in the epigastrium.
Allergic reactions: skin rash, itching, urticaria.
Pregnancy and Lactation:
Contraindicated in the first trimester of pregnancy.
In the second and third trimesters, and during breastfeeding, use only as prescribed by a physician.
Storage Conditions:
Store at a temperature not exceeding 30°C.
Packaging:
Cardboard box containing 100 tablets and a paper leaflet.